PRIMARY BILIARY CHOLANGITIS IN 2016: High-definition PBC: biology, models and therapeutic advances

    loading  Checking for direct PDF access through Ovid

Abstract

In 2016, obeticholic acid became the first new licensed therapy for primary biliary cholangitis in >20 years. This therapeutic came at a time of improved disease understanding from biliary and immunological mechanistic insights.

Related Topics

    loading  Loading Related Articles